DK0561877T3 - Forbindelser og præparater der hæmmer knogleresorption - Google Patents
Forbindelser og præparater der hæmmer knogleresorptionInfo
- Publication number
- DK0561877T3 DK0561877T3 DK92900438T DK92900438T DK0561877T3 DK 0561877 T3 DK0561877 T3 DK 0561877T3 DK 92900438 T DK92900438 T DK 92900438T DK 92900438 T DK92900438 T DK 92900438T DK 0561877 T3 DK0561877 T3 DK 0561877T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- bone resorption
- preparations
- compounds
- inhibit bone
- Prior art date
Links
- 208000006386 Bone Resorption Diseases 0.000 title abstract 2
- 230000024279 bone resorption Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 102000043299 Parathyroid hormone-related Human genes 0.000 abstract 2
- 101710123753 Parathyroid hormone-related protein Proteins 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000030991 negative regulation of bone resorption Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Mobile Radio Communication Systems (AREA)
- Transceivers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPK387990 | 1990-12-13 | ||
| AUPK956791 | 1991-11-19 | ||
| PCT/AU1991/000580 WO1992010511A1 (en) | 1990-12-13 | 1991-12-13 | Compounds and compositions which inhibit bone resorption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0561877T3 true DK0561877T3 (da) | 1999-12-27 |
Family
ID=25643990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92900438T DK0561877T3 (da) | 1990-12-13 | 1991-12-13 | Forbindelser og præparater der hæmmer knogleresorption |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5688760A (enExample) |
| EP (1) | EP0561877B1 (enExample) |
| JP (1) | JP3280021B2 (enExample) |
| AT (1) | ATE181336T1 (enExample) |
| AU (1) | AU666838B2 (enExample) |
| CA (1) | CA2096933C (enExample) |
| DE (1) | DE69131355T2 (enExample) |
| DK (1) | DK0561877T3 (enExample) |
| ES (1) | ES2135398T3 (enExample) |
| GR (1) | GR3030947T3 (enExample) |
| HU (1) | HUT64565A (enExample) |
| WO (1) | WO1992010511A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2158762A1 (en) * | 1993-04-08 | 1994-10-27 | Hans Rink | Cyclic compounds and compositions which inhibit bone resorption |
| GB9425582D0 (en) * | 1994-12-19 | 1995-02-15 | Iaf Biochem Int | Peptides having immunomodulatory activity |
| DE69637104T2 (de) * | 1995-02-20 | 2008-01-31 | Yukio Kato | Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen |
| DE69604936T2 (de) * | 1995-03-20 | 2000-05-18 | Shell Internationale Research Maatschappij B.V., Den Haag/S'gravenhage | Verfahren zur regeneration von katalysatoren |
| EP0902036A1 (en) * | 1997-09-05 | 1999-03-17 | Roche Diagnostics GmbH | Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds |
| JP4394279B2 (ja) * | 1998-03-09 | 2010-01-06 | ジーランド ファーマ アクティーゼルスカブ | 酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体 |
| JP2005525312A (ja) * | 2002-01-10 | 2005-08-25 | オステオトロフィン エルエルシー | 骨同化物質を用いた骨疾患の治療方法 |
| JP2006508646A (ja) * | 2002-08-15 | 2006-03-16 | バスキュロスタティン エルエルシー | ＰＴＨｒＰ由来の平滑筋増殖モジュレータ |
| KR20100058555A (ko) * | 2007-09-11 | 2010-06-03 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 ｂｐｐ－ｂ의 용도 |
| ES2605813B1 (es) * | 2015-09-16 | 2018-01-17 | Fundación Instituto De Investigación Sanitaria Fundación Jiménez Díaz | Uso de osteostatina en la preparación de un medicamento para el tratamiento de artrosis |
| US11858974B2 (en) * | 2017-05-22 | 2024-01-02 | Resq Biotech | Macrocyclic modulators of disease associated protein misfolding and aggregation |
| EP4713000A2 (en) * | 2023-05-15 | 2026-03-25 | Purdue Research Foundation | A cytokine-like propeptide gene therapy platform |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
| JPS63259972A (ja) * | 1987-04-17 | 1988-10-27 | Fuji Electric Co Ltd | 燃料電池設備 |
| US5312810A (en) * | 1987-05-20 | 1994-05-17 | The University Of Melbourne | Method and compositions for making ACSF and ACSF antagonists |
| JP2795657B2 (ja) * | 1987-05-20 | 1998-09-10 | ジェネンテク，インコーポレイテッド | Ａｃｓｆおよびａｃｓｆアンタゴニストの製造方法および組成物 |
| US4819504A (en) * | 1987-05-27 | 1989-04-11 | Sampson Sports, Inc. | Self contained braking system for bicycle pedals |
| EP0341962B1 (en) * | 1988-05-09 | 1995-03-15 | Merck & Co. Inc. | Humoral hypercalcemic factor antagonists |
| JP2752987B2 (ja) * | 1988-06-01 | 1998-05-18 | 株式会社東芝 | リン酸型燃料電池発電プラント |
-
1991
- 1991-12-13 DE DE69131355T patent/DE69131355T2/de not_active Expired - Lifetime
- 1991-12-13 US US08/064,111 patent/US5688760A/en not_active Expired - Lifetime
- 1991-12-13 ES ES92900438T patent/ES2135398T3/es not_active Expired - Lifetime
- 1991-12-13 AT AT92900438T patent/ATE181336T1/de not_active IP Right Cessation
- 1991-12-13 JP JP50160992A patent/JP3280021B2/ja not_active Expired - Lifetime
- 1991-12-13 EP EP92900438A patent/EP0561877B1/en not_active Expired - Lifetime
- 1991-12-13 DK DK92900438T patent/DK0561877T3/da active
- 1991-12-13 WO PCT/AU1991/000580 patent/WO1992010511A1/en not_active Ceased
- 1991-12-13 HU HU9301726A patent/HUT64565A/hu unknown
- 1991-12-13 CA CA002096933A patent/CA2096933C/en not_active Expired - Lifetime
- 1991-12-13 AU AU90632/91A patent/AU666838B2/en not_active Expired
-
1999
- 1999-08-10 GR GR990402028T patent/GR3030947T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE181336T1 (de) | 1999-07-15 |
| HU9301726D0 (en) | 1993-10-28 |
| WO1992010511A1 (en) | 1992-06-25 |
| CA2096933A1 (en) | 1992-06-14 |
| DE69131355T2 (de) | 1999-12-30 |
| JP3280021B2 (ja) | 2002-04-30 |
| HUT64565A (en) | 1994-01-28 |
| DE69131355D1 (de) | 1999-07-22 |
| AU666838B2 (en) | 1996-02-29 |
| GR3030947T3 (en) | 1999-11-30 |
| EP0561877A1 (en) | 1993-09-29 |
| CA2096933C (en) | 2003-05-13 |
| JPH06503330A (ja) | 1994-04-14 |
| EP0561877B1 (en) | 1999-06-16 |
| US5688760A (en) | 1997-11-18 |
| ES2135398T3 (es) | 1999-11-01 |
| AU9063291A (en) | 1992-07-08 |
| EP0561877A4 (enExample) | 1994-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ248377A (en) | Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors | |
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| HUP0004560A2 (hu) | Törést gyógyító PTHrP analógok | |
| ATE116335T1 (de) | Peptid-analoge vom insulinähnlichen wachstums- faktor 1 (igf-1) oder faktor 2 (igf-2). | |
| DK0561877T3 (da) | Forbindelser og præparater der hæmmer knogleresorption | |
| ATE73459T1 (de) | Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten. | |
| MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
| DE3851776D1 (de) | Verwendung von IGF-II zur Behandlung von Knochenkrankheiten. | |
| HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
| IL112111A0 (en) | Peptide derivatives and pharmaceutical compositions containing them | |
| DE69931793D1 (de) | Verfahren für die behandlung der multiplen sklerose mittels peptidanalogen des menschlichen basischen myelinproteins | |
| ATE377026T1 (de) | Behandlung von fettleibigkeit | |
| ATE213499T1 (de) | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose | |
| DE59209196D1 (de) | Menschliche il-4 mutantenproteine | |
| ES2139081T3 (es) | Composiciones farmaceuticas que contienen la hormona humana del crecimiento. | |
| NO931400L (no) | Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav | |
| DE69102069D1 (de) | 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen. | |
| SE9403055D0 (sv) | A new human peptide antibiotic (FALL-39) and its use | |
| YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
| ATE25984T1 (de) | Pharmakologisch aktive peptide. | |
| SE8203054L (sv) | Antihypertensivt medel | |
| SE8501202D0 (sv) | Human intestinal hormone and its use | |
| DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
| DE69220229D1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
| DK0722460T3 (da) | Peptidderivater der er terapeutisk aktive i blodkoaguleringskaskaden, fremgangsmåde til fremstilling heraf og farmaceutiske |